IIM
NAUT icon

INTECH Investment Management’s Nautilus Biotechnolgy NAUT Stock Holding History

INTECH Investment Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,391
Closed -$34.8K – 2595
2025
Q1 		$34.8K Buy
40,391
+19,440
+93% +$28.9K ﹤0.01% 2466
2024
Q4 		$35.2K Buy
+20,951
New +$50.1K ﹤0.01% 2356

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

INTECH Investment Management's NAUT Position: Q2 2025 in Review

INTECH Investment Management sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 40,391 shares — an estimated $34.8K sold.

INTECH Investment Management first reported a position in NAUT in Q4 2024 and held it in 2 quarters. The position peaked at $35.2K in Q4 2024. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • INTECH Investment Management reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • INTECH Investment Management sold 40,391 Nautilus Biotechnolgy shares in Q2 2025, an estimated $34.8K.
  • INTECH Investment Management first reported a position in Nautilus Biotechnolgy in Q4 2024 and held it in 2 quarters.
  • INTECH Investment Management's Nautilus Biotechnolgy position peaked at $35.2K in Q4 2024.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.